抗CAⅨ蛋白多糖区多肽的合成及其寻靶能力

朱连华; 郭燕丽; 范校周; 熊星宇; 黄海韵; 徐丹; 方可敬

您当前的位置：

首页 >

文章列表页 >

抗CAⅨ蛋白多糖区多肽的合成及其寻靶能力

基础医学 | 更新时间：2026-01-09

- 抗CAⅨ蛋白多糖区多肽的合成及其寻靶能力
- Synthesis of anti-CAⅨ proteoglycanlike region peptide and evaluation of its target binding ability
- 陆军军医大学学报 2016年38卷第17期页码：1905-1909
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R341;R914.5;R962
- 纸质出版：2016
- 稿件说明：
移动端阅览
朱连华,郭燕丽,范校周,熊星宇,黄海韵,徐丹,方可敬.抗CAⅨ蛋白多糖区多肽的合成及其寻靶能力[J].陆军军医大学学报(原第三军医大学学报),2016,38(17):1905-1909.

　Zhu Lianhua,Guo Yanli,Fan Xiaozhou,Xiong Xingyu,Huang Haiyun,Xu Dan,Fang Kejing.Synthesis of anti-CAⅨ proteoglycanlike region peptide and evaluation of its target binding ability[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(17):1905-1909.
朱连华,郭燕丽,范校周,熊星宇,黄海韵,徐丹,方可敬.抗CAⅨ蛋白多糖区多肽的合成及其寻靶能力[J].陆军军医大学学报(原第三军医大学学报),2016,38(17):1905-1909. DOI：

　Zhu Lianhua,Guo Yanli,Fan Xiaozhou,Xiong Xingyu,Huang Haiyun,Xu Dan,Fang Kejing.Synthesis of anti-CAⅨ proteoglycanlike region peptide and evaluation of its target binding ability[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(17):1905-1909. DOI：

摘要

目的合成能够与碳酸酐酶9（carbonic anhydrase Ⅸ，CAⅨ）蛋白多糖区特异性结合的多肽分子（proteoglycan-like region peptide

PGLR-P1）

并初步探讨其在体外的寻靶能力。方法通过化学固相合成法合成多肽分子，对其纯度和相对分子质量进行分析，并初步探讨其与CAⅨ蛋白、表达CAⅨ的肿瘤细胞和相应移植瘤组织的结合能力以及携载多肽的靶向纳米泡的体外寻靶能力。结果合成的多肽分子纯度高于98%，相对分子质量(1 722.2±0.4)，其能与CAⅨ蛋白、表达CAⅨ的肿瘤细胞及相应移植瘤组织发生特异性靶向结合，且携载多肽的靶向纳米泡特异性靶向结合CAⅨ表达阳性的肿瘤细胞。结论化学合成的多肽分子PGLR-P1在分子、细胞和组织水平均能与CAⅨ蛋白发生特异性结合。

Abstract

Objective To synthesize the peptide (PGLR-P1) specifically binding to the proteoglycan-like region of carbonic anhydrase Ⅸ (CAⅨ) and investigate its target binding ability in vitro. Methods The peptide was synthesized through the standard solid phase synthesis

its purity was measured

and its relative molecular weight was studied. Its target binding ability to CAⅨ protein

CAⅨ-positive tumor cells and transplanted tumor tissues

and the binding capacity of ultrasonic nanobubbles carrying the synthesized peptide to cells in vitro were investigated and analyzed. Results The purity of our synthesized peptide was higher than 98%

with a relative molecular weight of 1 722.2±0.4. It could bind targetly to CAⅨ-protein

CAⅨ-positive tumor cells and transplanted tumor tissue

and ultrasonic nanobubbles carrying the peptide were confirmed to bind targetly to CAⅨ-positive tumor cells. Conclusion The synthesized peptide PGLR-P1 can specifically and targetly bind to CAⅨ protein in molecular

cell and tissue levels.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

海洋生物活性肽对化疗期肿瘤患者营养状况的协同改善效应

源于VEGF_125-136肿瘤靶向抑制肽的¹⁸⁸Re标记及荷瘤裸鼠的显像研究

护理风险管理能有效提高糖尿病合并恶性肿瘤患者的化疗疗效

抑制人PC4基因表达的siRNA载体的构建与筛选

¹³¹I标记VEGFR-3高亲和融合多肽对荷人卵巢癌裸鼠靶向治疗的实验研究